Skip to content
All Podcasts – Lifestyle
Author:
Providence Therapeutics Holdings Inc
Providence Therapeutics Enrolls First Patient in World’s First Clinical Trial of a Personalized mRNA Vaccine for Pediatric Brain Cancer
November 18, 2026
Providence Therapeutics Announces Formation of Oncology Clinical Advisory Board
September 29, 2026